Immunology
Resource Center
Featured
05/31/2023
In this “Test Your Knowledge” quiz series, Melissa V. Cabellon, MD, PhD, asks you about which patient is the best candidate for the live-attenuated influenza vaccine.
05/31/2023
05/26/2023
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
05/26/2023
05/19/2023
This COVID-19 roundup includes coverage of the FDA’s simpler vaccination schedule and authorization of new treatment, decline in pediatric asthma diagnoses during pandemic, and a new treatment combination...
05/19/2023
Interactive Features
05/31/2023
In this “Test Your Knowledge” quiz series, Melissa V. Cabellon, MD, PhD, asks you about which patient is the best candidate for the live-attenuated influenza vaccine.
05/31/2023
07/10/2022
Children are defined as “persons aged 1 to 12 years.” How many vaccinations are recommended for the average child in the United States? Take our pop quiz to test your knowledge!
07/10/2022
03/24/2022
Your patient recently underwent a routine complete blood count (CBC) which showed an absolute neutrophil count of less than 1500/mL. No other abnormalities were present on the CBC.
03/24/2022
Clinical Insights
05/26/2023
In this video, Jonathan Silverberg, MD, PhD, MPH, discusses his team's study, which found that lebrikizumab was highly effective in treating symptoms of moderate-to-severe atopic dermatitis in adults and...
05/26/2023
05/01/2023
In this video, Amy S. Paller, MD, discusses the efficacy and safety of dupilumab for patients with erythrodermic atopic dermatitis (AD), what these results mean for patients with severe AD, and how her...
05/01/2023
